Notice NOT-OD-24-034 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-035 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-036 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DA-25-028 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity is to support the development of Clinical Outcome Assessments (COA) for Substance Use Disorders (SUD). The COA development plan is expected to progress into the FDA drug development tool qualification program. This notice of funding opportunity (NOFO) utilizes the UG3/UH3Phased Innovation Awards Cooperative Agreement grant mechanism that includes two phases. The applications responding to this NOFO should contain a COA development plan that will cover both UG3 and UH3 phases. In the first 2-year UG3 phasethe project must have a set of operational milestones to be completed by the end of this period. Once NIDA program has evaluated the progress of the UG3 phase and determined that the UG3 phase has been successfully completed, it transitions to the UH3 phase to be funded for three additional years.The goal of this NOFO is to expand the armamentarium of COA that are FDA qualified as drug development tool (DDT) in the context of use (COI) of a SUD. Achieving this goal will greatly facilitate the development of treatments for SUDs. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn. Applicants are strongly encouraged to read the NOFO instructions carefully and view the available PEDP guidance material.

Negotiable: Oxford Nanopore Technologies: Oxford Nanopore Technologies is headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices and a commercial presence in many Homeworking

Negotiable: AstraZeneca : Do you have expertise in algorithm development and computer sciences? Would you like to apply your expertise in image analysis / artificial intellige Munich, Germany

EUR 60,000 to 75,000 depending on candidate's experience: CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences: We are recruiting a Senior Bioinformatician / Biomedical Data Scientist to join the research groupled by Christoph Bock.... Vienna, Austria

Funding Opportunity RFA-NR-24-003 from the NIH Guide for Grants and Contracts. Care delivery has traditionally approached a patients health as separate and distinct from their social context. This practice must be reimagined to make meaningful improvements in health, eliminate health disparities, and advance health equity. The purpose of the Bridge-to-Care Initiative is to advance research that leverages healthcare-community partnerships to address unmet health-related social needs among individuals and families and adverse social determinants of health (SDOH) within communities.

Notice NOT-CA-24-021 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-072 from the NIH Guide for Grants and Contracts. Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical trial information as described in this FOA. This NOFO does not and will not support clinical trials for studies of cancer diagnosis and/or oncologic therapy in patients. The proposed investigator-initiated projects should be related to the programmatic interests of the NCI Division of Cancer Prevention and/or the NCI Division of Cancer Control and Population Sciences.

Funding Opportunity PAR-24-085 from the NIH Guide for Grants and Contracts. The purpose of this reissuance is to seek research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Notice NOT-OD-24-046 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-045 from the NIH Guide for Grants and Contracts

Negotiable: SRG: Required - an experienced Senior Bioinformatician to drive the analysis and interpretation of NGS data, generated using a unique epigenetics platform, as well as to develop ways to create patient epigenetic profiles and discover novel biomarkers for bot Cambridge, England

Negotiable: SRG: A Bioinformatics Engineer is required to join a small but rapidly expanding company - by joining early in the journey you will gain exposure to the various facets of start-up life and have a unique chance to contribute to the technology and influence co Cambridge, England

Notice NOT-DK-24-008 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-037 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-055 from the NIH Guide for Grants and Contracts. The purpose of this NOFO is to support the NIGMS Human Genetic Cell Repository (HGCR). The repository will maintain the current collection of cell cultures and DNA samples and will acquire, characterize, and expand high-quality cell samples and distribute cell lines and extracted DNA to qualified biomedical researchers.

Negotiable: SRG: We are seeking a Senior Data Manager to join a new multi-skilled team including data scientists, data managers, data visualisers, research software and cloud engineers. Oxford, England

Notice NOT-NS-24-042 from the NIH Guide for Grants and Contracts